Indy Hematology Review Presentation Archive 2020 EMERGING TREATMENT PARADIGMS IN MULTIPLE MYELOMA: TARGETING THE NEIGHBORHOOD AND BEYOND – Kenneth Anderson, MD STATE OF THE ART: 2020 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu E. Birhiray, MD. Chair INDY HEMATOLOGY REVIEW 2020 TOWNHALL: CASE PRESENTATION – Ruemu E. Birhiray, MD. Chair BAD BLOOD: TREATMENT OF COMPLIMENTINOPATHIES AND APLASTIC ANEMIA – Robert Brodsky, MD WHO, WHEN AND HOW TO TREAT: THE PARADOX OF WATCHING, TREATMENT AND RETREATMENT IN INDOLENT LYMPHOMAS IN 2020s – Bruce Cheson, MD, FACP, FAAS, FASCO HOW I TREAT: THE PRACTICE OF HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 2020 – Richard Childs, MD, RADM, USPHS CHRONIC LYMPHOCYTIC LEUKEMIA: WHO, WHEN AND HOW TO TREAT IN 2020 – Steven Coutre, MD NOVEL THERAPY OF ACUTE LYMPHOBLASTIC LEUKEMIA: DRIVERS, CARS AND TARGETED THERAPY – Hagop Kantarjian, MD BENIGN HEMATOLOGY: CURRENT TREATMENT OF CYTOPENIAS AND COAGULOPATHIES – Craig Kessler, MD CURRENT TREATMENT STRATEGIES OF MYELOPROLIFERATIVE NEOPLASMS – Rami Komrokji, MD CHRONIC MYELOID LEUKEMIA: THERAPEUTIC GOALS AND MANAGING RESISTANCE – Richard Larson, MD ACUTE MYELOID LEUKEMIA: PROGNOSTICATION, TARGETING AND SEQUENCING THERAPIES – Charles Schiffer, MD AGGRESSIVE LYMPHOMAS – Sonali Smith, MD MYELODYSPLASTIC SYNDROME: WHAT IS NEW IN 2020? – Richard Stone, MD WALDENSTRÖM’S MACROGLOBULINEMIA: CHOOSING WISELY IN PROGNOSTICATION AND TREATMENT IN 2020 – Steven Treon, MD, MA, PhD, FACP, FRCP CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP – Co-Chair
